Everything Genetic Multi-Cancer Panel

£399.00

This panel analyses 72 genes associated with the reported increased risk in at least one study of one or more of the following hereditary cancers: breast, colorectal, endometrial, gastric, melanoma, ovarian, pancreatic, prostate, renal, skin, thyroid, and uterine.

The test can be used to confirm the presence of a genetic variant in already diagnosed cancer patients, and to inform the presence of an increased risk to develop cancer from the same variant in the immediate relatives of the cancer patient.

It is also suitable for individuals with a family history of cancer to identify their risk of developing the disease due to an inherited genetic variant

  • More Information

    Why choose the Everything Genetic Multi-Cancer Panel?

    • Comprehensive gene panel – a cost-effective way to identify inherited disease-causing variants to help guide surgical and treatment decisions.
    • Germline genetic test – the identification of a genetic variant in a patient may guide the testing and management of at-risk relatives.
    • Accelerated turnaround time – enabling clinicians and patients to make surgical and treatment decisions quickly for better patient outcomes.
    • Clinically actionable results – helping clinicians and patients to develop personalised screening, prevention, and treatment plans.

Description

This panel analyses 72 genes associated with the reported increased risk in at least one study of one or more of the following hereditary cancers: breast, colorectal, endometrial, gastric, melanoma, ovarian, pancreatic, prostate, renal, skin, thyroid, and uterine.

The test can be used to confirm the presence of a genetic variant in already diagnosed cancer patients, and to inform the presence of an increased risk to develop cancer from the same variant in the immediate relatives of the cancer patient.

It is also suitable for individuals with a family history of cancer to identify their risk of developing the disease due to an inherited genetic variant